A recent study has uncovered a concerning link between severe respiratory infections, such as COVID-19 or influenza, and an increased risk of developing lung cancer years later. Researchers discovered that these infections can alter immune cells in the lungs, creating a persistent inflammatory state that may support tumor development.
New Study Reveals Link Between Respiratory Infections and Lung Cancer Risk
A recent study suggests a potential connection between severe respiratory infections and an increased likelihood of developing lung cancer years later. Researchers from UVA Health’s Beirne B. Carter Center for Immunology Research and the UVA Comprehensive Cancer Center found that serious viral infections, such as those caused by COVID-19 or influenza, may alter immune cells in the lungs, creating a persistent inflammatory state that could support tumor development. Published in the journal Cell, the study highlights the long-term health impacts of respiratory infections and underscores the role of vaccination in reducing these risks.
Study Combines Mouse and Human Data
The research integrated data from laboratory mice and human patients, revealing that severe lung infections—regardless of their cause, including pneumonia—were linked to a higher incidence of lung cancer. In mice, severe infections led to prolonged inflammation and immune cell modifications, fostering an environment conducive to tumor growth. Human data showed a 1.24 times greater risk of lung cancer among individuals hospitalized with severe COVID-19, irrespective of smoking status or other health conditions. This finding aligns with a separate study in Everyday Health, which reported a 2,4% elevated risk of lung cancer in people hospitalized for severe viral infections.
Immune Cell Reprogramming and Chronic Inflammation
The study identified specific changes in immune cells, particularly neutrophils and macrophages, which typically defend against infections. After severe viral infections, these cells underwent ‘reprogramming,’ leading to chronic inflammation that may promote cancer development. Neutrophils, which usually combat infections, began producing inflammatory molecules that support tumor growth. Additionally, epithelial cells lining the lungs and air sacs showed significant alterations, further contributing to a pro-tumor environment.
Chronic Inflammation and Cancer Risk
These results align with existing knowledge about how chronic inflammation contributes to cancer. For instance, hepatitis B virus is associated with liver cancer, and human papillomavirus (HPV) is linked to cervical cancer. The study suggests respiratory viruses may follow a similar pattern, triggering long-term changes in lung tissue that increase cancer susceptibility.
Vaccination as a Protective Measure
The research also highlights the protective role of vaccination in mitigating the harmful effects of severe viral infections. Observations showed that individuals vaccinated before contracting severe COVID-19 had lower rates of lung cancer compared to those who experienced severe infections without prior vaccination. Vaccines enhance the immune system’s response to pathogens, reducing illness severity and subsequent lung tissue damage.
Public Health Implications and Clinical Recommendations
The findings have significant implications for public health and clinical practices. Medical professionals are advised to monitor patients recovering from severe respiratory infections, especially those with a history of smoking or other lung conditions. Routine CT scans may be recommended for high-risk individuals to detect lung cancer at an early stage, when treatment is most effective.
Call to Treat Severe Infections as Established Risk Factors
Dr. Jeffrey Sturek, a collaborator on the study, stated that the results suggest treating severe respiratory viral infections similarly to established risk factors like smoking. ‘We’ve known for a long time that things like smoking increase the risk for lung cancer. The results from this study suggest we may need to think about severe respiratory viral infection similarly,’ he said. This perspective could lead to updated guidelines for lung cancer surveillance and prevention strategies.
Study Limitations and Future Research
The study has limitations, including potential biases in data from patients hospitalized before January 2022, which may have been influenced by earlier access to medical imaging and follow-up care. Additionally, the study primarily focused on hospitalized patients, leaving gaps in understanding risks for individuals with milder infections. Future research should address these gaps, including long-term follow-up studies of individuals with varying infection severity and broader population data. The study’s authors aim for their findings to contribute to new therapeutic strategies to mitigate the long-term effects of severe respiratory infections on lung health.
Call for Continued Public Health Vigilance
The research underscores the complex relationship between viral infections and cancer development, emphasizing the need for continued public health vigilance. While the risk of lung cancer following severe respiratory infections is notable, the study’s focus on vaccination highlights prevention as a critical measure. As the global health community addresses the long-term impacts of the pandemic, these findings reinforce the importance of proactive efforts to protect lung health and reduce cancer risk.
- sciencedaily.com | Severe COVID or flu may raise lung cancer risk years later
- uvahealth.com | Severe COVID 19, Flu Facilitate Lung Cancer Months or Years Later
- news.virginia.edu | Severe COVID 19, flu may raise lung cancer risk UVA Today
- wtop.com | Severe COVID 19 or flu raises risk of lung cancer, even years later ...
- unmc.edu | Severe COVID 19 and flu can facilitate lung cancer months or years ...
- everydayhealth.com | Severe Flu or COVID 19 Could Raise Lung Cancer Risk
